Happy Sunday ! I wanted to take the time when the market

New Post Public Reply Private Reply Replies (1) Message Board
MicroCapStocksRock JohnJohn #3277

Happy  Sunday ! I wanted to take the time when the market was closed to discuss the following three stocks, HHSE NTEK and MFST. Our due diligence has uncovered some pretty amazing things going on between NTEK and HHSE and between NTEK and MFST. We have alerted all three companies here on FISP and we own these three and continue adding more shares on all three. The reason why is simple, they all make $$$ and all are increasing their revenues by coming together and doing joint ventures with each other which then adds to their bottom lines. We love the CEOs at each company too. All very savvy men with solid business skills that have led their companies to profitability and increased cash flows. Let us take some time below to discuss each company and the due diligence we have compiled on each hot company to own. We also believe that each stock is  VERY undervalued at their current PPS and that will soon change as more and more folks find out about each company. The supply of shares in the market will dwindle while demand for the shares in these companies soars with their increasing revenues, profits and business developments. We are buyers of all three of these stocks based on our due diligence of these companies. We are not financial advisors so be sure to do your own due diligence of the companies and do not buy these companies based on our due diligence alone. Do your homework and you will see why we are buying these three stocks.

















HHSE


Hannover House became a publicly traded company in late 2009 when it reverse merged into the TDGI shell and subsequently went through a name and symbol change to HHSE. The stock went from 0.0015 to as high as 6.6 cents and was in a blue sky breakout but unfortunately the previous shell owner sold into that run with shares he should never have had. That unfortunate event is the only reason the stock is not well above 15-25 cents. The company in the meantime went through some growing pains and learned from a few business mistakes and has now become a very smart and savvy company with stronger margins and a business plan that is developing into one that will see the company at much much higher PPS prices. The company management gets it. They have an investors blog they use regularly to communicate with the investment community. They are very protective of their share structure. They reduce the share structure over time as they can with share retirements and the management conducts their business and investor relations as if it were a fully transparent Nadsaq company with annual shareholder meetings in person with management, the investor blog, disclosure statements and now 8K filings. The company is voluntarily submitting 8Ks, 10Qs to SEC Edgar system and will soon have their Form 10 and 2 years of audited financials approved for the move to OTCQB, expected any time now. Eric Parkinson who was the CEO of Hemdale (a Nasdaq Company) knows the entertainment business better than most. He is very connected to Hollywood and all the major motion picture companies and has strong business relationships with all major retailers including Walmart, Bet Buy, Amazon, etc. The company jointly announced that they will be launching VODwiz which is a joint venture between HHSE and NTEK to provide the general public video on demand service for thousands of independent titles. This internet streaming service is another choice like Netflix or Hulu but brings thousands of titles not available through these other content providers. We love the HHSE potential as both a company and a VERY undervalued stock. We are buyers of the stock indefinitely. From a charting perspective, the stock has a golden cross forming on the daily chart and it looks as though that powerful technical event will take place in the very near future. See Daily chart below.





NTEK



Nanotech Entertainment (OTC: NTEK) is the HOTTEST Tech stock on the OTC by far. The company is making money hand over fist. They are projected to do $33M in revenues for 2014. They have announced quarterly dividends that will increase to shareholders as profits continue to grow. The company has developed the Nuvola NP-1. This product is the world's first streaming media player that supports 4K Ultra HD Movies. It has the fastest mobile processor on the market today and is set up with major wholesale distributors and major retailers to be announced in the near future. The company through its JV with HHSE is also partners in their own video on demand service for thousands of independent titles leveraging Hannover House's expertise in the movie industry which will mean increased profits for the company. The company has joint ventures and businss with partners such as MFST who is going to have its own ROKU channel under the NTEK umbrells for a health channel again adding revenue and profit to NTEK. NTEK is a monster high tech company that is definitely NASDAQ BX bound once it stays on the OTCQB for a specified time frame starting this summer when its audited financials and Form 10 are approved by the SEC. We love the stock and we have been using the recent pullback to buy up a ton of shares and continue to add to this winner. Dividends start paying in April. CEO is top notch. No brainer investment for one's portfolio as a tech stock. From the look of the daily chart below, we have nice bounce in procees with money flowing in, accumulation going up, MACD crosses and TRIX about to cross up. RSI has plenty of room to run too. We love the technicals on the daily NTEK chart!




MFST



Medifirst Solutions (OTCQB: MFST) is an SEC reporting medical company that is currently doing busness in New Jersey/New York area and in their new medical center in Boca Raton, Florida. Medifirst Solutions has established practice services and protocols to generate new revenues by establishing a specialized "medical services" within the practice. Medical, healthcare and wellness services and products are designed to help patients achieve better outcomes in their overall health and well-being. Using cutting-edge and innovative technology, we have created exciting new healthcare and medical services and products for the healthcare and mental health industry.  They are dedicated to provide innovative drug free and pain free treatments, services and products for people to make better and healthier choices and improve their quality of life. Additionally, MFST management has decided to enter the Medical Marijuana industry with the State of Florida approving MJ as a medical treatment and several other states where Medifirst Solutions will leverage their medical expertise. They have a medical doctor on staff, Dr. Rubin is a licensed medical doctor in several states. MFST has a very solid joint venture with NTEK for a roku channel that will be used for their products and shows designed by Medifirst staff to introduce these cutting edge technologies and will publish many Medical MJ shows nationally as well. We are buyers of this stock. We love the share stucture which is only 10.2M shares in its float and 15M shares in its OS. The CEO is very respected in the industry and is very protective of its share structure and his shareholders. The sky is the limit for this company and we expect a strong move up in share price as the company gets discovered by the investment community. At this point the stock is still very much a hidden gem but that will not last much longer as marketing kicks in nationally though trade shows, TV, radio, magazines, social media and PR/IR campaigns continue positively.


Nanotech Entertainment Inc. (NTEK) Stock Research Links

NTEK Board Company Profile Buy Rating Time & Sales News Filings Financials
My Favorite plays are on the Nasdaq DIP and RIP Board http://investorshangout.com/NASDAQ-DIP-and-RIP-87909/
My Favorite Paid chat room with amazing chart setups is The Trading Stock Lounge http://www.thetradingstocklounge.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WEPSEA 2026 Propels Southeast Asia's Packaging Leap

Updated Category News Views 1

Revolution in Packaging: Southeast Asia Steps Up Get ready for a wake-up call in the world of packaging, folks; the Southeast Asian market is taking a sharp turn toward sustainability and technological advancement, as highlighted by WEPSEA 2026's recent wrap-up in Shanghai. Far from a mere exhibition, this gathering served as the crucible for change, where old-school...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 3

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Softcare Facilitates Standards Delegation Visit to Senegal

Updated Category News Views 3

Ever seen a whole nation's hygiene industry getting a deep dive from not just one, but three major standards bodies? That's what just went down in Senegal. Softcare opened its doors wide to folks from the Senegalese Association for Standardization (ASN), the International Organization for Standardization (ISO), and the Swedish Institute for Standards (SIS). This was no...

Continue Reading

Top 5 Most Recently Viewed Articles

Prinses Máxima Center Enhances Genomics with Callisto™ Innovation

Updated Category News Views 194

Prinses Máxima Center's Partnership with Volta Labs The Prinses Máxima Center for Pediatric Oncology is making headlines with its recent acquisition of the Callisto™ platform from Volta Labs. This major step forward aims to enhance efficiency in sample preparation across a variety of genomics workflows, specifically designed for both Illumina and Oxford Nanopore...

Continue Reading
Boise Hunter Homes Appoints Industry Veteran Julie DeLorenzo

Updated Category News Views 474

Julie DeLorenzo Joins Boise Hunter Homes Boise Hunter Homes welcomes Julie DeLorenzo to its team as the new Director of Community Relations. This strategic move emphasizes the company’s commitment to community building and corporate stewardship. Experience and Community Commitment DeLorenzo comes with extensive experience as an Idaho Realtor, and her dedication to...

Continue Reading
Growth Prospects for Glass Prefilled Syringes in Europe

Updated Category News Views 151

Emerging Trends in the European Market for Glass Prefilled Syringes The market for glass prefilled syringes and vials in Europe is undergoing significant transformations as we witness a rapid development in healthcare and biotechnology sectors. The competitive landscape is shifting, with the adoption of innovative packaging techniques, the rise of biologics as a treatment...

Continue Reading
Man Group PLC Announces Significant Shareholdings Update

Updated Category News Views 112

Clarifying Share Interests of Man Group PLC Understanding the ownership structure in the financial world is crucial for investors. In compliance with the rules set out by the Takeover Code, disclosures regarding significant shareholdings need to be clear and transparent. Recently, Man Group PLC has taken steps to outline its relevant investments, specifically in relation...

Continue Reading
Nutrien Faces Downgrade as UBS Revises Outlook and Price Target

Updated Category News Views 87

UBS Downgrades Nutrien's Rating Amid Agricultural Concerns UBS has recently made headlines by downgrading Nutrien (NYSE: NTR) from a "buy" to a "neutral" rating. This adjustment reflects growing concerns about the agricultural market's performance and the potential impact on the company’s financial health. Weaker Agricultural Market Outlook Analysts at UBS have...

Continue Reading